Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.

Iana Sousa Nascimento Massimo RadinAna Paula Rossi GândaraSavinio SciasciaDanieli Castro Oliveira de Andrade

Published in: Lupus (2020)

Our data show a significant correlation between a validated risk score such as GAPSS and the novel antiphospholipid antibody aß2GPI-DI. Future studies are needed. However, one could speculate a role of aß2GPI-DI as a risk-stratifying tool for thrombotic events in APS.

Keyphrases

biofilm formation
systemic lupus erythematosus
electronic health record
current status
big data
case control
escherichia coli
machine learning
candida albicans
data analysis
deep learning
cystic fibrosis
artificial intelligence